
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10255083
[patent_doc_number] => 20150140080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/610291
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33774
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14610291
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/610291 | COMPOSITIONS AND METHODS FOR TREATMENT | Jan 29, 2015 | Abandoned |
Array
(
[id] => 10290579
[patent_doc_number] => 20150175578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/610346
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33793
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14610346
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/610346 | COMPOSITIONS AND METHODS FOR TREATMENT | Jan 29, 2015 | Abandoned |
Array
(
[id] => 10593355
[patent_doc_number] => 09314425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Ophthalmic compositions and methods for treating ophthalmic conditions'
[patent_app_type] => utility
[patent_app_number] => 14/598818
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5657
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598818
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598818 | Ophthalmic compositions and methods for treating ophthalmic conditions | Jan 15, 2015 | Issued |
Array
(
[id] => 10233278
[patent_doc_number] => 20150118273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'NIACINAMIDE CONTAINING COSMETIC COMPOSITIONS WITH IMPROVED SKINFEEL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 14/584935
[patent_app_country] => US
[patent_app_date] => 2014-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5746
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14584935
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/584935 | NIACINAMIDE CONTAINING COSMETIC COMPOSITIONS WITH IMPROVED SKINFEEL PROPERTIES | Dec 28, 2014 | Abandoned |
Array
(
[id] => 10256335
[patent_doc_number] => 20150141333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'KERATIN BIOCERAMIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/547839
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7124
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547839
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/547839 | Keratin bioceramic compositions | Nov 18, 2014 | Issued |
Array
(
[id] => 9895998
[patent_doc_number] => 20150051198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'Highly Concentrated Stable Meloxicam Solutions for Needleless Injection'
[patent_app_type] => utility
[patent_app_number] => 14/526973
[patent_app_country] => US
[patent_app_date] => 2014-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2489
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14526973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/526973 | Highly concentrated stable meloxicam solutions for needleless injection | Oct 28, 2014 | Issued |
Array
(
[id] => 12367182
[patent_doc_number] => 09957262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Opioid analgesic
[patent_app_type] => utility
[patent_app_number] => 15/032070
[patent_app_country] => US
[patent_app_date] => 2014-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7240
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15032070
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/032070 | Opioid analgesic | Oct 27, 2014 | Issued |
Array
(
[id] => 9806482
[patent_doc_number] => 20150018428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'LUTEIN/ZEAXANTHIN FOR GLARE PROTECTION'
[patent_app_type] => utility
[patent_app_number] => 14/497802
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1769
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14497802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/497802 | LUTEIN/ZEAXANTHIN FOR GLARE PROTECTION | Sep 25, 2014 | Abandoned |
Array
(
[id] => 11031490
[patent_doc_number] => 20160228446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'Combination Drug Therapy'
[patent_app_type] => utility
[patent_app_number] => 15/022561
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18368
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022561 | Combination Drug Therapy | Sep 15, 2014 | Abandoned |
Array
(
[id] => 11023618
[patent_doc_number] => 20160220574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'NSAID AND SIGMA RECEPTOR LIGAND COMBINATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/021050
[patent_app_country] => US
[patent_app_date] => 2014-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13348
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021050
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/021050 | NSAID AND SIGMA RECEPTOR LIGAND COMBINATIONS | Sep 10, 2014 | Abandoned |
Array
(
[id] => 11560447
[patent_doc_number] => 09623007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Optical correction'
[patent_app_type] => utility
[patent_app_number] => 14/479852
[patent_app_country] => US
[patent_app_date] => 2014-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3060
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14479852
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/479852 | Optical correction | Sep 7, 2014 | Issued |
Array
(
[id] => 11009644
[patent_doc_number] => 20160206598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'THERAPEUTIC AGENT FOR DYSLIPIDEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/913064
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6099
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913064 | THERAPEUTIC AGENT FOR DYSLIPIDEMIA | Aug 26, 2014 | Abandoned |
Array
(
[id] => 10961463
[patent_doc_number] => 20140364494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE'
[patent_app_type] => utility
[patent_app_number] => 14/469764
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17533
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14469764
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/469764 | Processes for making cyclic lipid implants for intraocular use | Aug 26, 2014 | Issued |
Array
(
[id] => 11009651
[patent_doc_number] => 20160206604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'FORMULATIONS COMPRISING WETTING AGENTS AND COMPOUNDS FOR THE MODULATION OF HEMOGLOBIN (S)'
[patent_app_type] => utility
[patent_app_number] => 14/914554
[patent_app_country] => US
[patent_app_date] => 2014-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6425
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914554
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914554 | FORMULATIONS COMPRISING WETTING AGENTS AND COMPOUNDS FOR THE MODULATION OF HEMOGLOBIN (S) | Aug 24, 2014 | Abandoned |
Array
(
[id] => 10987309
[patent_doc_number] => 20160184254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'COMPOSITIONS COMPRISING VITAMIN K DERIVATIVES AND SALTS'
[patent_app_type] => utility
[patent_app_number] => 14/910855
[patent_app_country] => US
[patent_app_date] => 2014-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12828
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910855
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/910855 | COMPOSITIONS COMPRISING VITAMIN K DERIVATIVES AND SALTS | Aug 5, 2014 | Abandoned |
Array
(
[id] => 11002576
[patent_doc_number] => 20160199526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'OPHTHALMIC SOLUTION'
[patent_app_type] => utility
[patent_app_number] => 14/914066
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6889
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914066
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914066 | Ophthalmic solution | Aug 4, 2014 | Issued |
Array
(
[id] => 10938947
[patent_doc_number] => 20140341968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'Intraocular Drug Delivery Systems'
[patent_app_type] => utility
[patent_app_number] => 14/450011
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23395
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450011
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/450011 | Intraocular Drug Delivery Systems | Jul 31, 2014 | Abandoned |
Array
(
[id] => 10812034
[patent_doc_number] => 20160158194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'Methods and Treatments for the Learning and Memory Deficits Associated with Noonan Syndrome'
[patent_app_type] => utility
[patent_app_number] => 14/900907
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 20446
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900907
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/900907 | Methods and treatments for the learning and memory deficits associated with Noonan syndrome | Jun 26, 2014 | Issued |
Array
(
[id] => 10975390
[patent_doc_number] => 20140378426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Methods and compositions for enhancing visual function'
[patent_app_type] => utility
[patent_app_number] => 14/120727
[patent_app_country] => US
[patent_app_date] => 2014-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14120727
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/120727 | Methods and compositions for enhancing visual function | Jun 19, 2014 | Abandoned |
Array
(
[id] => 13165551
[patent_doc_number] => 10098867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Use of phytocannabinoids in the treatment of ovarian carcinoma
[patent_app_type] => utility
[patent_app_number] => 14/899613
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1952
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899613
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/899613 | Use of phytocannabinoids in the treatment of ovarian carcinoma | Jun 18, 2014 | Issued |